Cerebral Embolic Protection and the Low Risk TAVR Patient

October 28, 2021

As TAVR is used on more patients with low and intermediate risk, we have seen that unfortunately, even with newer technology and implant techniques, stroke does persist. In this product workshop, Drs. James E. Harvey and Suzanne J. Baron review the data around stroke incidence in TAVR, the impact and cost it can have on patients and hospitals, and how cerebral protection can help minimize the risk of stroke. Referencing clinical studies and case examples, they show how the SENTINEL™ Cerebral Protection System can help prevent neurological events in patients by capturing and removing potentially dangerous debris during TAVR.
Login to view comments. Click here to Login